Burton DR - Search Results

1

Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo.

Deruaz M, Moldt B, Le KM, Power KA, Vrbanac VD, Tanno S, Ghebremichael MS, Allen TM, Tager AM, Burton DR, Luster AD. Deruaz M, et al. Among authors: burton dr. J Infect Dis. 2016 Aug 15;214(4):612-6. doi: 10.1093/infdis/jiw203. Epub 2016 Jun 29. J Infect Dis. 2016. PMID: 27357340 Free PMC article.

2

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF 3rd, Burton DR, Mosier DE. Parren PW, et al. Among authors: burton dr. AIDS. 1995 Jun;9(6):F1-6. doi: 10.1097/00002030-199506000-00001. AIDS. 1995. PMID: 7662189

3

Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.

Sanna PP, De Logu A, Williamson RA, Hom YL, Straus SE, Bloom FE, Burton DR. Sanna PP, et al. Among authors: burton dr. Virology. 1996 Jan 1;215(1):101-6. doi: 10.1006/viro.1996.0011. Virology. 1996. PMID: 8553581 Free article.

4

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

Gauduin MC, Parren PW, Weir R, Barbas CF, Burton DR, Koup RA. Gauduin MC, et al. Among authors: burton dr. Nat Med. 1997 Dec;3(12):1389-93. doi: 10.1038/nm1297-1389. Nat Med. 1997. PMID: 9396610

5

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR. Poignard P, et al. Among authors: burton dr. Immunity. 1999 Apr;10(4):431-8. doi: 10.1016/s1074-7613(00)80043-6. Immunity. 1999. PMID: 10229186 Free article.

6

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.

Parren PW, Marx PA, Hessell AJ, Luckay A, Harouse J, Cheng-Mayer C, Moore JP, Burton DR. Parren PW, et al. Among authors: burton dr. J Virol. 2001 Sep;75(17):8340-7. doi: 10.1128/jvi.75.17.8340-8347.2001. J Virol. 2001. PMID: 11483779 Free PMC article.

7

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Parren PW, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. Parren PW, et al. Among authors: burton dr. J Virol. 2002 Jun;76(12):6408-12. doi: 10.1128/jvi.76.12.6408-6412.2002. J Virol. 2002. PMID: 12021376 Free PMC article.

8

Antibodies, viruses and vaccines.

Burton DR. Burton DR. Nat Rev Immunol. 2002 Sep;2(9):706-13. doi: 10.1038/nri891. Nat Rev Immunol. 2002. PMID: 12209139 Review.

9

GP120: target for neutralizing HIV-1 antibodies.

Pantophlet R, Burton DR. Pantophlet R, et al. Among authors: burton dr. Annu Rev Immunol. 2006;24:739-69. doi: 10.1146/annurev.immunol.24.021605.090557. Annu Rev Immunol. 2006. PMID: 16551265 Review.

10

Fc receptor but not complement binding is important in antibody protection against HIV.

Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR. Hessell AJ, et al. Among authors: burton dr. Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106. Nature. 2007. PMID: 17805298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters